Metagenomi Therapeutics - 2 Year Stock Price History | MGX
Historical daily share price chart and data for Metagenomi Therapeutics since 2024 adjusted for splits and dividends. The latest closing stock price for Metagenomi Therapeutics as of February 09, 2026 is 1.53.
- The all-time high Metagenomi Therapeutics stock closing price was 15.00 on February 08, 2024.
- The Metagenomi Therapeutics 52-week high stock price is 3.95, which is 158.2% above the current share price.
- The Metagenomi Therapeutics 52-week low stock price is 1.23, which is 19.6% below the current share price.
- The average Metagenomi Therapeutics stock price for the last 52 weeks is 1.90.
| Metagenomi Therapeutics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 1.6431 | 1.6700 | 1.8000 | 1.4100 | 1.5300 | -5.56% |
| 2025 | 2.0337 | 3.7900 | 3.7900 | 1.2600 | 1.6200 | -55.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.058B | $0.052B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $39.788B | 12.35 |
| BridgeBio Pharma (BBIO) | United States | $13.114B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.756B | 18.29 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.962B | 24.25 |
| Bausch Health Cos (BHC) | Canada | $2.181B | 1.55 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.345B | 9.69 |
| Taysha Gene Therapies (TSHA) | United States | $1.263B | 0.00 |
| Personalis (PSNL) | United States | $0.715B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.415B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.183B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |